Try The Trial
First in Human efficacy data at a fixed price
VC Ready. Proof of Concept. Fixed Scope. Agreed Timelines.
a product of
Top 10 Gobal CRO
The Vision:
The Leader of Innovation
Innovation in clinical research is no longer just about new science — it’s about new ways of delivering services.
Imagine buying a clinical trial the way you buy software: fixed price, clear scope, predictable delivery. That’s SaaP – Service as a Product – a new model that converts complex clinical services into standardized, scalable, and easy-to-access solutions.
First in Human. Venture Capital Ready.
Proof of Concept. All at fixed price, scope & agreed timelines!
The Problem:
The Liquidity Squeeze.
The global biopharma market is facing a crisis. Venture capital is concentrated, and investors now demand human clinical data before committing meaningful capital.
The Solution:
Try The Trial.
We provide cost-efficient, well-structured First-in-Human (FIH), Venture-Capital-Ready trials capable of delivering early safety and proof-of-concept signals—turning "unpredictable burn rates" into fixed, investable assets. We give innovators the confidence to move from discovery into human studies with greater speed, clarity, and efficiency.
in partnership with
Why Tigermed
is the preferred partner?
Tigermed is one of the world’s largest CROs by revenue and clinical trial volume, operating in more than 50 countries with over 5000 completed trials.
Ranked among the top 10 global CROs, the company has been publicly listed on the Hong Kong Stock Exchange since 2019 and has maintained global operations since 2004.
Tigermed is the leading CRO in China and the largest in Asia, with extensive operations across EMEA & CIS and North America.
You get the flexibility and pricing of a smaller CRO, backed by the infrastructure and quality of a top-10 global CRO.